XML 31 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
Taxes on Income
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Taxes on Income Taxes on Income
Income before taxes on income resulting from domestic and foreign operations is as follows:
(in millions)Year Ended December 31,
 202320222021
Domestic operations$1,899 $3,426 $2,874 
Foreign operations1,772 1,276 1,290 
Total income before taxes$3,671 $4,702 $4,164 

The provision for taxes on income consists of the following:
(in millions)Year Ended December 31,
 202320222021
Federal:
Current$559 $928 $438 
Deferred(177)(185)(9)
Total federal382 743 429 
Foreign:
Current370 322 295 
Deferred(150)(98)23 
Total foreign220 224 318 
State and local:
Current216 265 153 
Deferred(40)(52)1 
Total state and local176 213 154 
Total provision for taxes $778 $1,180 $901 

A reconciliation of the U.S. federal statutory income tax rate to our effective income tax rate for financial reporting purposes is as follows:
Year Ended December 31,
 202320222021
U.S. federal statutory income tax rate21.0 %21.0 %21.0 %
State and local income taxes3.5 3.9 3.3 
Foreign operations(5.1)(2.8)(0.2)
Stock-based compensation(0.4)— (0.8)
S&P Dow Jones Indices LLC joint venture(1.5)(1.1)(1.1)
Tax credits and incentives(2.0)(1.3)(2.3)
Divestitures1.8 2.9 — 
Other, net3.9 2.5 1.7 
Effective income tax rate 21.2 %25.1 %21.6 %

Fluctuation in tax rates by year is primarily due to tax charge on merger related divestitures and change in mix of income by jurisdiction.
We have elected to recognize the tax on Global Intangible Low Taxed Income (“GILTI”) as a period expense in the year the tax is incurred. GILTI expense is included in Other, net above.

The principal temporary differences between the accounting for income and expenses for financial reporting and income tax purposes are as follows: 
(in millions)December 31,
20232022
Deferred tax assets:
Accrued expenses$249 $179 
Loss carryforwards495 537 
Research & Development Expenditures258 136 
Other473 476 
Total deferred tax assets1,475 1,328 
Deferred tax liabilities:
Goodwill and intangible assets(4,573)(4,864)
Other(212)(174)
Total deferred tax liabilities(4,785)(5,038)
Net deferred income tax asset before valuation allowance(3,310)(3,710)
Valuation allowance(316)(274)
Net deferred income tax liability$(3,626)$(3,984)
Reported as:
Non-current deferred tax assets$64 $81 
Non-current deferred tax liabilities(3,690)(4,065)
Net deferred income tax liability$(3,626)$(3,984)

We record valuation allowances against deferred income tax assets when we determine that it is more likely than not that such deferred income tax assets will not be realized based upon all the available evidence. The valuation allowance is primarily related to operating losses.

As of December 31, 2023, we have approximately $7.1 billion of undistributed earnings of our foreign subsidiaries, of which $4.3 billion is reinvested indefinitely in our foreign operations. We have not recorded deferred income taxes applicable to undistributed earnings of foreign subsidiaries that are indefinitely reinvested in foreign operations. Quantification of the deferred tax liability, if any, associated with indefinitely reinvested earnings is not practicable.

We made net income tax payments totaling $1,279 million in 2023, $1,555 million in 2022, and $883 million in 2021. As of December 31, 2023, we had net operating loss carryforwards of $1,177 million, of which a significant portion has an unlimited carryover period under current law.

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
(in millions)Year ended December 31,
 202320222021
Balance at beginning of year$223 $147 $121 
Additions based on tax positions related to the current year21 28 35 
Additions for tax positions of prior years10 62 9 
Reduction for settlements(11)— (8)
Expiration of applicable statutes of limitations(13)(14)(10)
Balance at end of year$230 $223 $147 

The total amount of federal, state and local, and foreign unrecognized tax benefits as of December 31, 2023, 2022 and 2021 was $230 million, $223 million and $147 million, respectively, exclusive of interest and penalties. During the year ended December 31, 2023, the change in unrecognized tax benefits resulted in a net increase of tax expense of $5 million.
We recognize accrued interest and penalties related to unrecognized tax benefits in interest expense and operating-related expense, respectively. Based on the current status of income tax audits, we believe that the total amount of unrecognized tax benefits on the balance sheet may be reduced by up to approximately $12 million in the next twelve months as a result of the resolution of local tax examinations and expiration of applicable statutes of limitations. In addition to the unrecognized tax benefits, we had accrued interest and penalties associated with unrecognized tax benefits of $50 million and $38 million as of December 31, 2023 and 2022, respectively.

The U.S. federal income tax audits for 2018 through 2023 are in process. During 2023, we completed state and foreign tax audits and, with few exceptions, we are no longer subject to federal, state, or foreign income tax examinations by tax authorities for the years before 2015. The impact to tax expense in 2023, 2022 and 2021 was not material.

We file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions, and we are routinely under audit by many different tax authorities. We believe that our accrual for tax liabilities is adequate for all open audit years based on an assessment of many factors including past experience and interpretations of tax law. This assessment relies on estimates and assumptions and may involve a series of complex judgments about future events. It is possible that tax examinations will be settled prior to December 31, 2024. If any of these tax audit settlements do occur within that period, we would make any necessary adjustments to the accrual for unrecognized tax benefits.

For tax years beginning after December 31, 2021, the Tax Cuts and Jobs Act of 2017 (“TCJA”) requires taxpayers to capitalize and amortize research and development costs pursuant to Internal Revenue Code (“IRC”) Section 174. Section 174 requires taxpayers to capitalize research and development costs and amortize them over 5 years for expenditures attributed to domestic research and 15 years for expenditures attributed to foreign research. This provision affected a significant proportion of the Company for the first time in 2023. During 2023, our cash taxes were adversely impacted by the requirement to capitalize and amortize research and development expenses under Section 174. Although Congress is considering legislation that would reinstate and extend Section 174 expensing for certain research and experimental expenditures, the possibility that this will happen is uncertain.